The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prevalence of mutations associated with NCCN criteria for hereditary prostate cancer testing in an Indian population.
 
Rui Miguel Bernardino
No Relationships to Disclose
 
Atul Batra
Stock and Other Ownership Interests - Caplin Point Laboratories; Glenmark; Laurus; Zydus Pharmaceuticals
Research Funding - Alkem Laboratories; Astellas Pharma; AstraZeneca
 
Jessica Grace Cockburn
No Relationships to Disclose
 
Tiiu Sildva
No Relationships to Disclose
 
Marian Wettstein
No Relationships to Disclose
 
Sneha Gund
No Relationships to Disclose
 
Sunakshi Chowdhary
No Relationships to Disclose
 
Mikaeel Ghany
No Relationships to Disclose
 
Sayeed Ahmed
No Relationships to Disclose
 
Heidi Wagner
No Relationships to Disclose
 
Mohammad R. Akbari
No Relationships to Disclose
 
Neil E. Fleshner
Leadership - POINT Biopharma; Verity Pharmaceuticals
Stock and Other Ownership Interests - Verity Pharmaceuticals
Honoraria - Abbvie; Amgen; Astellas Medivation; Bayer; Ferring; Janssen Oncology; Sanofi
Research Funding - Janssen Oncology (Inst); Nucleix (Inst); Progenics (Inst)